Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea
Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and C...
Saved in:
Published in | Endocrinology and metabolism (Seoul) Vol. 36; no. 3; pp. 688 - 696 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Endocrine Society
01.06.2021
대한내분비학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2093-596X 2093-5978 2093-5978 |
DOI | 10.3803/EnM.2021.1000 |
Cover
Abstract | Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment.
The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used.
The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly.
Overall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate. |
---|---|
AbstractList | Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment.BACKGROUNDOnly a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment.The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used.METHODSThe nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used.The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly.RESULTSThe 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly.Overall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate.CONCLUSIONOverall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate. Background Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing’s disease and their survival analysis according to treatment. Methods The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing’s disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. Results The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing’s disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing’s disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing’s disease ameliorated the survival rate significantly. Conclusion Overall, the incidence of prolactinoma and Cushing’s disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing’s disease for improving the survival rate. Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment. The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly. Overall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate. Background: Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing’s disease and their survival analysis according to treatment. Methods: The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing’s disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. Results: The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing’s disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing’s disease. The survival benefit was insignificant in prolactinoma according to treatment, but the treatment of Cushing’s disease improved the survival rate significantly. Conclusion: Overall, the incidence of prolactinoma and Cushing’s disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing’s disease for improving the survival rate. KCI Citation Count: 0 |
Author | Park, Jin Sun Lee, Jung Kuk Chin, Sang Ouk Park, So Young Yun, Soo Jin |
Author_xml | – sequence: 1 givenname: Jin Sun orcidid: 0000-0001-8831-8344 surname: Park fullname: Park, Jin Sun – sequence: 2 givenname: Soo Jin surname: Yun fullname: Yun, Soo Jin – sequence: 3 givenname: Jung Kuk surname: Lee fullname: Lee, Jung Kuk – sequence: 4 givenname: So Young surname: Park fullname: Park, So Young – sequence: 5 givenname: Sang Ouk orcidid: 0000-0001-5914-3653 surname: Chin fullname: Chin, Sang Ouk |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34218648$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002728715$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNptks9u1DAQhy1UREvpkSvKEQ5Z_C-Jc0FabZeyoggEReJmBmeydZvYi52stLe-Bq_Hk-DdbSuKuNiW55tvLPn3lBw475CQ54xOhKLi9dx9mHDK2YRRSh-RI05rkRd1pQ7uz-W3Q3IS41UCqFKScfaEHArJmSqlOiLfTzGaYFeDXWM2X9kGe-s7v9xk4JrsyxjWdg1dNnXQbaKNmW-zT8F3YAbrfA9xh83GeGnd8vfNr5id2ogQMbMue-8DwjPyuIUu4sntfky-vp1fzN7l5x_PFrPpeW6kqoYclGgZr3jJagOmKXlrFLQUC25okyqpqqgRtVIKOU1w2UrJWAMVQ0AEcUxe7b0utPraWO3B7val19dBTz9fLHRdc8rqIrGLPdt4uNKrYHsIm13D7sKHpYYwWNOhVmhqYVgpyqKWIBkYrKSivGpMVdWVTK43e9dq_NFjY9ANAboH0ocVZy_Tm9Za8UIJrpLg5a0g-J8jxkH3NhrsOnDox6h5IVWZFsoT-uLvWfdD7r4zAWIPmOBjDNhqYwcYrN-Otp1mVG9zo1Nu9DY3epub1JX_03Un_j__B4iZxKQ |
CitedBy_id | crossref_primary_10_1210_endrev_bnac010 crossref_primary_10_1001_jama_2023_11305 crossref_primary_10_1016_j_eprac_2024_10_016 |
Cites_doi | 10.1210/jc.86.1.117 10.1530/eje-14-0144 10.7326/0003-4819-130-10-199905180-00015 10.1007/s11102-012-0454-0 10.1016/s0025-6196(12)60417-0 10.1111/cen.12020 10.1530/eje-07-0358 10.1210/jc.2006-1668 10.1677/erc.0.0080287 10.1530/eje-16-0117 10.1007/s11102-015-0701-2 10.1530/eje.0.1510439 10.1530/eje-13-1031 10.1210/jcem.84.8.5896 10.1016/b978-0-444-59602-4.00011-3 10.1210/jc.85.4.1420 10.1093/ije/dyw253 10.1210/jcem-62-6-1173 10.1007/bf03344942 10.1007/s11102-015-0655-4 10.1111/j.0954-6820.1988.tb15881.x 10.1007/s11102-020-01084-6 10.1530/eje-15-0189 10.1111/j.1365-2265.2009.03667.x 10.1590/2359-3997000000195 10.1111/j.1365-2265.1994.tb02486.x 10.1210/jc.2010-0537 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Korean Endocrine Society 2021 |
Copyright_xml | – notice: Copyright © 2021 Korean Endocrine Society 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA ACYCR |
DOI | 10.3803/EnM.2021.1000 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2093-5978 |
EndPage | 696 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9920195 oai_doaj_org_article_8ec93c1636594a41ace748027dc77974 PMC8258328 34218648 10_3803_EnM_2021_1000 |
Genre | Journal Article |
GroupedDBID | 5-W 53G 5VS 8JR 8XY AAYXX ABDBF ACUHS ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EF. GROUPED_DOAJ HYE HZB KQ8 M48 OK1 PGMZT RPM ADRAZ CGR CUY CVF ECM EIF IPNFZ NPM RIG 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c487t-a83f1272619cacd62fc8af0e52c0df123f180c39888e2083f6f4411da71eaeea3 |
IEDL.DBID | M48 |
ISSN | 2093-596X 2093-5978 |
IngestDate | Sun Mar 09 07:54:20 EDT 2025 Wed Aug 27 01:32:15 EDT 2025 Thu Aug 21 18:02:53 EDT 2025 Fri Jul 11 00:38:49 EDT 2025 Wed Feb 19 02:27:27 EST 2025 Tue Jul 01 01:37:48 EDT 2025 Thu Apr 24 23:13:48 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Pituitary ACTH hypersecretion Prolactinoma Survival analysis Prevalence Epidemiology Incidence |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c487t-a83f1272619cacd62fc8af0e52c0df123f180c39888e2083f6f4411da71eaeea3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Current affiliation: Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
ORCID | 0000-0001-5914-3653 0000-0001-8831-8344 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3803/EnM.2021.1000 |
PMID | 34218648 |
PQID | 2548625402 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9920195 doaj_primary_oai_doaj_org_article_8ec93c1636594a41ace748027dc77974 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8258328 proquest_miscellaneous_2548625402 pubmed_primary_34218648 crossref_citationtrail_10_3803_EnM_2021_1000 crossref_primary_10_3803_EnM_2021_1000 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-06-01 |
PublicationDateYYYYMMDD | 2021-06-01 |
PublicationDate_xml | – month: 06 year: 2021 text: 2021-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Endocrinology and metabolism (Seoul) |
PublicationTitleAlternate | Endocrinol Metab (Seoul) |
PublicationYear | 2021 |
Publisher | Korean Endocrine Society 대한내분비학회 |
Publisher_xml | – name: Korean Endocrine Society – name: 대한내분비학회 |
References | ref13 ref12 ref15 ref14 ref11 ref10 ref32 ref2 ref1 ref17 ref16 ref19 ref18 (ref31) 2015 ref24 ref23 ref26 Harris (ref28) 1989 Ritchie (ref22) 1990 ref25 ref20 ref21 ref27 ref29 ref8 ref7 ref9 ref3 Ezzat (ref30) 2004 ref6 ref5 Park (ref4) 2015 |
References_xml | – volume-title: Rare intractable pituitary diseases: analysis on their epidemiology and use of benefit extension policy (No. 2015-20-025) year: 2015 ident: ref4 – ident: ref24 doi: 10.1210/jc.86.1.117 – volume-title: National Health Insurance System of Korea [Internet] year: 2015 ident: ref31 – ident: ref9 doi: 10.1530/eje-14-0144 – ident: ref26 doi: 10.7326/0003-4819-130-10-199905180-00015 – ident: ref7 doi: 10.1007/s11102-012-0454-0 – ident: ref29 doi: 10.1016/s0025-6196(12)60417-0 – ident: ref20 doi: 10.1111/cen.12020 – ident: ref16 doi: 10.1530/eje-07-0358 – ident: ref1 doi: 10.1210/jc.2006-1668 – ident: ref12 doi: 10.1677/erc.0.0080287 – ident: ref14 doi: 10.1530/eje-16-0117 – ident: ref17 doi: 10.1007/s11102-015-0701-2 – ident: ref21 doi: 10.1530/eje.0.1510439 – ident: ref11 doi: 10.1530/eje-13-1031 – ident: ref23 doi: 10.1210/jcem.84.8.5896 – ident: ref10 doi: 10.1016/b978-0-444-59602-4.00011-3 – ident: ref3 doi: 10.1210/jc.85.4.1420 – start-page: 55 volume-title: Ascertainment and natural history of treated acromegaly in Northern Ireland year: 1990 ident: ref22 – ident: ref32 doi: 10.1093/ije/dyw253 – ident: ref27 doi: 10.1210/jcem-62-6-1173 – ident: ref18 doi: 10.1007/bf03344942 – ident: ref19 doi: 10.1007/s11102-015-0655-4 – ident: ref15 doi: 10.1111/j.0954-6820.1988.tb15881.x – ident: ref25 doi: 10.1007/s11102-020-01084-6 – ident: ref13 doi: 10.1530/eje-15-0189 – ident: ref6 doi: 10.1111/j.1365-2265.2009.03667.x – start-page: 417 volume-title: The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours year: 1989 ident: ref28 – ident: ref5 doi: 10.1590/2359-3997000000195 – ident: ref2 doi: 10.1111/j.1365-2265.1994.tb02486.x – start-page: 613 volume-title: The prevalence of pituitary adenomas: a systematic review year: 2004 ident: ref30 – ident: ref8 doi: 10.1210/jc.2010-0537 |
SSID | ssj0000884121 |
Score | 2.2345328 |
Snippet | Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing... Background Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are... Background: Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 688 |
SubjectTerms | epidemiology Humans Incidence Original pituitary acth hypersecretion Pituitary ACTH Hypersecretion - epidemiology Pituitary Neoplasms - epidemiology prevalence prolactinoma Prolactinoma - epidemiology Survival Analysis 내과학 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQiK8ARS6qOBHVjp3EPkLZqh8qQoJKezOOY8OqyKm2u5W48Tf4e_wSZux0u4tAXDhFip3IGdvj9-LxG0J2ORMC1mVdVrzXJeDbUHZdHWBetQ3KnduswHf6rjk8k8fTerqW6gtjwrI8cDbcnvJOCweooam1tJJb51upgEz1rm0BDKP3ZZqtkankg5WSPB26gkJR1rqZZoFNoZjYm8RTYIYVxxABtrEgJd1-WGbiPPwJcv4eObm2FB3cJXdGDElf57bfI7d8vE8-AYPMHuDK08lN3tdv1MaefliCS7jCh0YREjoE-n4OvBb8XcQYoVRtf5n-SP38_uOSvs1bN3QW6ckA0PIBOTuYfNw_LMf0CaUDFrIorRKBVy1SJGdd31TBKRuYryvHeiiBUsWc0MCBfQVILDQBsBHvbcu99d6Kh2QrDtE_JtRa3gbvgQo2tbSd7OANspedRHFmF3hBXl3b0LhRWxxTXHw1wDHQ5AZMbtDkqJHMCvJyVf0ii2r8reIb7JBVJdTCTjdghJhxhJh_jZCCvIDuNOdulp7H6-fBnM8NMIYjo3WFZyYLsnPd2wYmGO6a2OiH5aUBBg2sD4BtVZBHufdX7RESU3pJVZB2Y1xsNHizJM6-JBFvYObgTNWT__GFT8ltNFmOYHtGthbzpd8GrLTonqdp8QvBHw_H priority: 102 providerName: Directory of Open Access Journals |
Title | Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34218648 https://www.proquest.com/docview/2548625402 https://pubmed.ncbi.nlm.nih.gov/PMC8258328 https://doaj.org/article/8ec93c1636594a41ace748027dc77974 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002728715 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Endocrinology and Metabolism, 2021, 36(3), , pp.688-696 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWq9sIFgVpK-Fi5CHEiEDtO4hxQRctWLWgrJFhpb8Zx7LJq5UB2t2pv_A3-Hr-kM066ZaHcOEWKnSgZZ2bes503hDxnSZpCXi5jzuoyBnzr4qrKHPhVkaPcue4U-EbH-eFYvJ9kkxtJod6As1upHdaTGrdnry6-X-6Cw79BximT9PXQj4DocYYr_sDeNyAp5cjDRj3SD0FZSsHCX1gcOHyclfmkU9z8-w4rGSoI-UPe8a27DYP-uZXyt9x0cI_c7UElfdt9BffJmvWb5AtQyi4knFs6vCkEe0m1r-mnBcSIc7yoVyWhjaMfW7AGBECPm4ZCt_1FmKL69ePnjL7r1nLo1NMPDWDNLTI-GH7eP4z7egqxAVoyj7VMHeMFciajTZ1zZ6R2ic24SWpogVaZmLQEUmw5QDOXOwBLrNYFs9panT4g677x9iGhWrPCWQvcMM-ErkQFdxC1qASqNRvHIvLy2obK9GLjWPPiTAHpQJMrMLlCk6NochKRF8vu3zqVjX913MMBWXZCcexwomlPVO9rSlpTpgaAZp6VQgumjS2EBP5dm6IA_hSRZzCc6tRMw_V4PGnUaauAQhypsuT4E2VEdq5HW4HH4TKK9rZZzBRQaqCBgHR5RLa70V8-TyqwxpeQESlWvouVB15t8dOvQdUbqDpEV_nof7zhY3IHTdZtaXtC1uftwj4F8DSvBmHSYRCcYxDmtq4AicgZAw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Descriptive+Epidemiology+and+Survival+Analysis+of+Prolactinomas+and+Cushing%E2%80%99s+Disease+in+Korea&rft.jtitle=Endocrinology+and+metabolism+%28Seoul%29&rft.au=Jin+Sun+Park&rft.au=Soo+Jin+Yun&rft.au=Jung+Kuk+Lee&rft.au=So+Young+Park&rft.date=2021-06-01&rft.pub=Korean+Endocrine+Society&rft.issn=2093-596X&rft.eissn=2093-5978&rft.volume=36&rft.issue=3&rft.spage=688&rft.epage=696&rft_id=info:doi/10.3803%2FEnM.2021.1000&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_8ec93c1636594a41ace748027dc77974 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-596X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-596X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-596X&client=summon |